LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Factsheet – Vision for Europe: Innovation

11/10/2022
FACTSHEET

Innovation

Europe must lead the world in scientific and industrial innovation.

Science
Create an environment which fosters scientific progress which will result in tangible social benefits.

Regulation
Establish a future-proof EU regulatory framework which removes barriers to innovation and allows tomorrow’s technologies to be developed and launched in Europe first.

Infrastructure
Strengthen the links between scientific knowledge and industrial capabilities by encouraging partnerships that can support infrastructures for biotechnology to ensure efficient, impactful, and rapid progress.

Competitiveness
Provide companies with the appropriate tools, incentives, and frameworks to ensure they can compete globally.

Growth
Harness the innovation created by the healthcare biotechnology sector to unleash its economic potential, creating high-skill jobs and value for citizens.

Accessibility
Address regulatory barriers and other factors to improve accessibility of therapeutic innovations for the benefits of patients.

Factsheet - Vision for Europe: Innovation


Download
Europabio-Factsheets-Page1_InnovationDownload
Share
Communications Team
Communications Team

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.